What are the top regenerative agriculture startups by revenue?

The ranking of top startups in the regenerative agriculture market by revenue

Below is a table ranking all the companies in this market by their current revenue scale. You can find our methodology at the end of this page.

If you want a deeper understanding of the market and its current dynamics, get our report covering the Regenerative Agriculture Market.

What actually counts as a regenerative agriculture startup?

The answer changes a lot depending on whether we mean actual startups or every large company now selling regenerative agriculture products.

At the broadest level, regenerative agriculture includes biological crop inputs, microbial fertilizers, soil analytics, carbon farming, regenerative agronomy, MRV software, agroforestry and businesses that help farmers change how they manage soil and crops.

The problem is that several of the biggest companies in these categories are clearly no longer startups. Rovensa Next was assembled from 12 established biosolutions businesses. DE SANGOSSE traces its history back a century. Koppert was founded in 1967. Biobest has also grown into a large international group.

They still matter because they show how large a regenerative agriculture business can become. But putting them next to a venture-backed company such as Pivot Bio without explaining the difference gives a misleading picture of the startup market.

We therefore look at the market in two ways. The broader ranking shows the largest regenerative agriculture businesses for which we found useful revenue evidence. The stricter ranking focuses on independent, startup-like companies where the comparison makes more sense.

Which regenerative agriculture companies make the most revenue today?

The biggest regenerative agriculture businesses currently generate hundreds of millions in annual revenue, but almost all of that scale sits in biological crop inputs.

Rovensa Next says its revenue exceeds €500 million. Floridienne's latest annual report puts Biobest at roughly €500 million of turnover and €100 million of EBITDA. DE SANGOSSE has reached about €490 million.

Koppert reported €417 million back in 2022. That figure is now old enough that we would not confidently place it ahead of fresher disclosures simply because the number is larger.

Bioceres Crop Solutions provides the cleanest recent public-company accounts. Its latest SEC-filed results show $238.3 million of FY2026 revenue from continuing operations. That is down sharply from the $335 million reported for FY2025 and $465 million a year earlier, partly because the business perimeter changed and its Pro Farm Group operation was classified as discontinued.

Biotrop sits below those groups but is still huge compared with most startups. CEO Jonas Hipólito told Exame that the company finished 2025 with R$900 million of revenue after growing 23%.

Then the market drops sharply. Pivot Bio is the clearest independent startup above $100 million. Grow Indigo is around the mid-$20-million range, while Advancing Eco Agriculture's last detailed financial disclosure was about $18 million.

Company	Best current revenue evidence	Period	What it mainly sells
Rovensa Next	>€500M	Current disclosed scale	Biosolutions
Biobest	~€500M turnover	Current disclosed scale	Biocontrol and pollination
DE SANGOSSE	~€490M	Recent group scale	Biosolutions and agricultural inputs
Koppert	€417M	2022	Biological crop protection and pollination
Bioceres Crop Solutions	$238.3M	FY2026	Crop protection, nutrition and seeds
Biotrop	R$900M	2025	Microbial biological inputs
Pivot Bio	>$100M	FY2023	Microbial nitrogen
Grow Indigo	₹207 Cr	FY2025	Biological inputs and carbon farming
Advancing Eco Agriculture	$18.0M	2023	Regenerative agronomy and inputs
Elicit Plant	€5M–€8M	Recent disclosed scale	Biostimulants
Biome Makers	€5.7M	2025	Soil microbiome intelligence
Varaha	₹430M	Latest reported financial year	Agricultural carbon projects

Is Pivot Bio the biggest true regenerative agriculture startup by revenue?

Pivot Bio is currently the strongest answer we found for the largest independent regenerative agriculture startup by disclosed revenue.

The company crossed $100 million of annual revenue in FY2023 after growing more than 60% year over year. Pivot Bio reported that number directly, so we are dealing with company revenue rather than an external estimate, acreage figure or future contract.

That disclosure is no longer fresh. We looked for a newer revenue figure and did not find a stronger one. Still, nothing else in the independent startup group comes close on verified revenue.

Pivot Bio also fits the category unusually well. Founded in 2011, the company built a microbial nitrogen product designed to replace part of the synthetic nitrogen farmers normally apply. It grew through venture financing and commercial expansion rather than through the consolidation of older agricultural businesses.

For now, Pivot Bio holds a fairly clear lead among the companies we would actually call regenerative agriculture startups.

Are Rovensa Next, Biobest and DE SANGOSSE really startups?

Rovensa Next, Biobest and DE SANGOSSE are better understood as large regenerative agriculture companies than startups.

Their scale is impressive. Rovensa Next reports more than €500 million of revenue, more than 2,200 employees and operations in over 90 countries. Its portfolio covers biostimulants, biofertilizers, bionutrition, biocontrol and adjuvants.

Biobest has reached roughly €500 million of turnover, according to Floridienne's latest annual report. The same report gives approximately €100 million of EBITDA, which puts the business on a completely different financial scale from most venture-backed regenerative agriculture companies.

DE SANGOSSE is close behind at roughly €490 million. The company says biosolutions are central to its next phase of growth and has set a goal of doubling group revenue by 2030.

Those numbers show the ceiling of this market pretty clearly. Biological agriculture can already support businesses approaching half a billion euros in yearly sales.

They tell us much less about what a startup can realistically reach. That is why we keep these companies in the broader market comparison but outside the strict startup ranking.

How big is Bioceres Crop Solutions now?

Bioceres Crop Solutions is still a major regenerative agriculture player, but its latest results are much weaker than the numbers from a year ago.

The company's latest SEC-filed FY2026 results show $238.3 million in revenue. FY2025 had come in at roughly $335 million, while FY2024 reached about $465 million.

So Bioceres has lost almost half of the revenue scale it reported two years earlier.

There is some accounting complexity here. Pro Farm Group was classified as discontinued operations after a foreclosure process, while the continuing company has also been reshaping its seeds business. We therefore would not treat the fall as a simple measure of underlying demand for regenerative products.

Bioceres is also broader than a pure regenerative startup. Its portfolio includes biological crop nutrition and biocontrol, but also conventional crop-protection products, seed technologies and integrated seed solutions.

The company remains one of the biggest businesses in our market map, although $238.3 million is now the figure that best represents its current continuing operations rather than the older $335 million number.

How big has Biotrop become?

Biotrop has grown into a roughly R$900 million biological-input company, making it one of the biggest startup success stories to come out of this market even though it is no longer independent.

Exame reported that Biotrop grew 23% in 2025 and finished the year with R$900 million in revenue. Management is now targeting more than R$1 billion.

The company was only founded in 2018. That makes its growth particularly striking compared with the much older groups sitting above it.

Biotrop has also reached more than 50 million hectares treated with its biological technologies, according to CEO Jonas Hipólito. Brazil still accounts for roughly 90% of sales, while the company is expanding in the United States and Europe.

Ownership changes how we treat the number. Biobest acquired about 85% of Biotrop in 2023, so Biotrop's sales cannot simply be added to Biobest's group turnover when estimating the size of the overall market.

As seen above, this is one reason the broad leaderboard can look much bigger than the independent startup ecosystem underneath it.

How much revenue does Grow Indigo make?

Grow Indigo generated ₹207 crore in FY2025, putting it comfortably among the largest independent regenerative agriculture startups with recent financial data.

Inc42's financial data shows revenue rising from ₹195 crore in FY2024 to ₹207 crore in FY2025, an increase of about 6%.

That is roughly a mid-$20-million business at representative exchange rates.

Grow Indigo is interesting because it has two commercial engines. It sells biological agricultural products while also developing regenerative agriculture and soil-carbon programs.

That makes it less dependent on one emerging revenue stream than a pure carbon-credit startup. Farmers can already buy the company's products, while carbon projects create another way to make money from regenerative practices.

The company is still far behind Pivot Bio's last disclosed $100 million-plus level, but Grow Indigo currently has the strongest recent revenue evidence we found among the next tier of independent startups.

How much revenue does Advancing Eco Agriculture make?

Advancing Eco Agriculture generated $18.0 million in 2023, which still makes it one of the largest dedicated regenerative agriculture startups for which we have detailed company financials.

The company's investor report showed $18.05 million of revenue in 2023, versus $18.66 million in 2022. Sales therefore slipped by roughly 3%.

AEA also said it had worked with more than 10,000 growers across around four million acres. Its business combines regenerative crop inputs, plant and soil testing, agronomy and consulting.

The revenue number is unusually useful because AEA disclosed actual financial statements rather than an estimated company profile. The weakness is simply age: we do not have an equally solid figure for 2025 or 2026.

We keep AEA near the top of the strict startup list, but Grow Indigo's newer ₹207 crore disclosure gives us a much better view of current scale.

Which regenerative agriculture startups have crossed $10 million in revenue?

Confirmed eight-figure startup revenue is still surprisingly rare in regenerative agriculture.

Pivot Bio has passed $100 million.

Grow Indigo is around the mid-$20-million range.

Advancing Eco Agriculture last reported about $18 million.

After that, the evidence gets much thinner. Two Brothers Organic Farms generated ₹98.6 crore in FY2025, roughly low-double-digit millions of dollars, but we do not include it in the strict core ranking because much of the company is a consumer food business rather than a regenerative agriculture technology or service platform.

Plant Health Care produced roughly $11 million of 2023 revenue, although PI Industries completed its acquisition of the company in 2024.

That leaves only a handful of genuinely independent regenerative agriculture startups with confirmed annual sales above $10 million.

For a sector with many heavily funded companies and millions of acres under programs, that is a pretty small club.

Which smaller regenerative agriculture startups are already making millions?

Several regenerative agriculture startups have now built real businesses in the $4 million to $8 million range.

Elicit Plant has recently been reported at roughly €5 million to €8 million of annual revenue. Its biostimulants are designed to help crops handle water stress, and the company has expanded approvals across Europe, Brazil and the United States.

Biome Makers generated €5.7 million in 2025, up from €5.0 million in 2024 and €4.5 million in 2023. The company applies DNA sequencing and data analysis to soil microbiology, and its technology supported 1.3 million hectares according to its latest impact report.

Varaha reported ₹430 million, around $4.8 million, in revenue from delivered carbon credits for its last financial year. CEO Madhur Jain told TechCrunch that the company expects to get close to ₹1 billion this year. We treat that second number as guidance, not current revenue.

Below that, BioPrime Agrisolutions reported ₹10.8 crore in FY2025, up 153% year over year. eAgronom's Estonian statutory accounts show €976,863 of 2025 revenue for the parent entity.

These companies are beyond the pilot stage. What we do not yet see is a deep bench of startups moving smoothly from $5 million to $20 million and then on toward $100 million.

Why are biological-input companies making so much more money?

Biological inputs currently dominate regenerative agriculture revenue because they fit into budgets farmers already have.

Farmers already spend heavily on nitrogen, crop protection, seed treatment and plant nutrition. A microbial fertilizer or biocontrol product can take part of that existing spend if it performs well enough.

That is a much easier commercial path than asking farmers to start paying for an entirely new software product or waiting for carbon-credit revenue that depends on verification, issuance and a buyer.

The top of the market shows the result. Rovensa Next, Biobest, DE SANGOSSE, Koppert and Biotrop all sell physical biological products. Pivot Bio, the largest startup in our strict ranking, also sells a product that replaces part of an existing input budget.

The same pattern appears lower down. Elicit Plant sells crop biostimulants. BioPrime sells biological products. Advancing Eco Agriculture derives most of its business from products and agronomic services.

Today, regenerative agriculture makes the most money when it can sell farmers something concrete that fits into the economics of growing a crop.

Are regenerative agriculture carbon startups making much revenue yet?

Regenerative agriculture carbon startups are finally producing meaningful revenue, although their contract and project volumes are still much larger than the revenue figures we can actually verify.

Varaha is one of the cleanest examples. It generated roughly $4.8 million in its last reported financial year from delivered carbon credits and expects much stronger revenue this year.

Other companies reveal their scale differently.

Grassroots Carbon says it has made $40 million in direct payments to ranchers since 2022 and has delivered 1.9 million tonnes of carbon removals.

Soil Capital says cumulative payments to farmers have passed £17.6 million. Its program now works with more than 1,600 farmers managing 385,000 hectares.

Indigo signed a 12-year deal to sell Microsoft 2.85 million soil-carbon credits.

Those are serious commercial operations. They still do not tell us exactly how much annual corporate revenue Grassroots Carbon, Soil Capital or Indigo Carbon is keeping after farmer payments, project costs and other obligations.

Carbon farming has reached real economic scale, while company-level revenue disclosure is still patchy.

Does having millions of acres mean a regenerative agriculture startup is making a lot of money?

Millions of acres prove that a regenerative agriculture company can operate at scale, but acreage alone tells us very little about revenue.

Agreena currently works with farmers across roughly five million hectares in 20 European markets.

Boomitra says its projects cover around five million acres and benefit more than 100,000 farmers and ranchers.

Regrow Ag monitors around 1.4 billion acres globally and works with more than 100 customers across the agricultural value chain.

These are huge footprints, yet each business monetizes land differently.

One company may sell software to a food company. Another can take part of carbon-credit proceeds. Another may be paid for measurement and verification. Some programs include direct farmer incentives funded by corporate buyers.

An acre managed through one platform can therefore be worth many times more revenue than an acre touched by another.

We use acreage to understand adoption and operating reach. We do not turn those acres into imaginary revenue.

How big are Agreena and Regrow Ag if they do not disclose revenue?

Agreena and Regrow Ag are clearly large regenerative agriculture platforms today, even though public revenue data is not strong enough to place either one precisely in a financial ranking.

Agreena says it works with thousands of farmers across approximately five million hectares in 20 markets. The company now describes itself as moving into a new phase focused on profitable growth and commercial scale.

Regrow Ag says more than 100 organizations use its technology. Those customers have collectively invested more than $19 million through programs that help farmers adopt regenerative practices. Regrow also says its platform monitors around 1.4 billion acres of agricultural land worldwide.

That puts both companies well beyond experimental scale.

Revenue could still differ dramatically between them because acreage monitored, farmer payments and customer investment are not the same thing as company sales.

Agreena and Regrow belong among the most important companies in regenerative agriculture right now, but we would rather leave their revenue position uncertain than invent a clean-looking number.

Are regenerative agriculture carbon contracts the same thing as revenue?

Large carbon contracts can show strong demand, but they should not be treated as revenue already earned.

Indigo's Microsoft agreement covers 2.85 million soil-carbon removal credits over 12 years. That is one of the largest regenerative agriculture carbon deals we found.

Mitti Labs has now announced a one-million-credit agreement with Google linked to methane reductions and water savings in rice farming.

Google has also expanded its relationship with Terradot through an agricultural project in Brazil. The latest agreement includes one million tonnes of methane-elimination impact by 2030 and one million tonnes of permanent carbon removal by 2040.

These deals can be economically enormous.

The revenue is usually recognized as delivery happens, sometimes over many years. Contract value can also include money that will eventually go to farmers, verification providers and other project participants.

We therefore keep contracted offtake separate from annual revenue. Combining the two would make early-stage carbon companies look far bigger than their current financial statements justify.

Which regenerative agriculture business models have actually reached scale?

Biological inputs are currently the only regenerative agriculture business model that has repeatedly produced companies with hundreds of millions in annual revenue.

Microbial fertilizer has also demonstrated serious scale through Pivot Bio and Biotrop.

Integrated biological-input and carbon businesses are one step behind. Grow Indigo has reached more than ₹200 crore of annual revenue, showing that the model can already support a meaningful operating company.

Dedicated regenerative agronomy has reached the high teens in millions of dollars through Advancing Eco Agriculture.

Soil intelligence and biostimulant startups are currently more often in the mid-single-digit millions.

Carbon and MRV platforms present a stranger picture. Some already cover millions of acres and work with major global companies, but their disclosed corporate revenue remains limited or unavailable.

Business model	Strongest commercial scale we found	Where the model stands today
Biological inputs / biosolutions	~€500M businesses	Mature
Microbial nitrogen / microbial inputs	>$100M startup revenue and much larger acquired businesses	Proven at scale
Biological inputs + carbon farming	₹207 Cr annual startup revenue	Scaling
Regenerative agronomy and crop inputs	~$18M disclosed revenue	Established niche
Biostimulant startups	~€5M–€8M revenue	Early scale
Soil microbiome intelligence	~€5.7M revenue	Early scale
Agricultural carbon development	Millions in revenue plus very large long-term contracts	Scaling, hard to compare
Regenerative MRV / software	100+ customers or millions of hectares, limited revenue disclosure	Large operational reach, unclear financial scale

Where are the biggest regenerative agriculture startups being built?

The regenerative agriculture startup market is now spread across the United States, Brazil, India and Europe rather than dominated by one tech hub.

The United States produced Pivot Bio and Advancing Eco Agriculture, while companies such as Regrow Ag, Grassroots Carbon and Indigo have become important parts of the carbon and MRV layer.

Brazil has become a powerhouse in biological inputs. Biotrop reached R$900 million of revenue only a few years after launch, and Gênica has also built a sizeable microbial-products business.

India is moving quickly. Grow Indigo has crossed ₹200 crore of annual revenue. Varaha is already generating millions from carbon credits. BioPrime's revenue more than doubled in FY2025.

Europe looks particularly strong in regenerative finance, soil-carbon programs and biological crop protection. Agreena, Soil Capital and eAgronom sit alongside much older biosolutions leaders such as Biobest, Koppert and DE SANGOSSE.

These days, the geography depends heavily on the business model. Brazil stands out for bioinputs, the US for venture-backed agricultural technology, India for newer biological-and-carbon models, and Europe for both mature biosolutions and regenerative transition platforms.

Is regenerative agriculture already consolidating?

Consolidation has already started, especially in biological inputs where successful products can plug straight into large agricultural distribution networks.

Biotrop is the obvious case. Founded in 2018, it grew into one of Brazil's largest biological-input companies and was then acquired by Biobest in a deal valuing the company at roughly R$2.8 billion.

Plant Health Care followed another version of the same path. PI Industries completed its acquisition in 2024 after the business generated about $11 million in 2023 revenue.

Rovensa Next shows what this can eventually become. Rather than growing from one startup, the platform brought together 12 companies with different biosolutions capabilities and now reports more than €500 million of revenue.

Acquisitions make sense in this market. Large agricultural companies already have sales teams, distributors, regulatory experience and relationships with farmers. A biological startup can bring technology that would take years to develop internally.

For founders, reaching $500 million of standalone revenue is only one possible outcome. Building a valuable biological product and selling into a larger platform is already a well-established route.

How concentrated is regenerative agriculture revenue right now?

Regenerative agriculture revenue is extremely concentrated at the top.

Several broad-market biosolutions businesses sit around €400 million to €500 million.

Biotrop has reached hundreds of millions of reais.

Pivot Bio is above $100 million based on its last disclosure.

Then we fall to Grow Indigo at ₹207 crore, roughly the mid-$20-million range.

Advancing Eco Agriculture is around $18 million on its last detailed accounts, and the next cluster is mostly below $10 million.

The gap is much bigger than the usual startup narrative suggests. There are plenty of regenerative agriculture companies, but very few have publicly shown the ability to turn adoption into tens of millions of dollars of annual revenue.

As pointed out above, some carbon and software companies may be larger than their public figures suggest. We simply do not have enough direct revenue evidence to move them up.

That leaves a market with lots of operating activity but a surprisingly thin middle between small commercial startups and the handful of companies that have reached serious scale.

Which regenerative agriculture startups could move up the ranking next?

Grow Indigo, Varaha, Elicit Plant, Biome Makers and BioPrime currently have some of the clearest paths to a higher revenue tier.

Grow Indigo is already at ₹207 crore, so crossing the equivalent of $30 million would not require a radical change in scale.

Varaha is smaller today, but management expects revenue to rise from ₹430 million to nearly ₹1 billion. That growth still has to happen, yet the company has already delivered credits and signed long-term agreements with buyers including Google and Microsoft.

Elicit Plant has reached roughly €5 million to €8 million and is expanding internationally through crop approvals and distribution partnerships. Physical products have historically scaled well in this market once distribution works.

Biome Makers has grown from €4.5 million in 2023 to €5.7 million in 2025 and expects further growth. Its challenge is turning a large soil-data footprint into much more revenue.

BioPrime is starting from a lower base, but FY2025 revenue jumped 153% to ₹10.8 crore. At that size, another year of triple-digit growth would change its place in the ranking quickly.

These are the companies where a fresh financial disclosure could meaningfully redraw the startup leaderboard.

Are regenerative agriculture startups actually getting big?

A few regenerative agriculture startups are getting big, but the market is much less mature financially than its acreage, funding rounds and corporate partnerships make it look.

Pivot Bio has already proven that an independent startup can cross $100 million of annual revenue.

Grow Indigo has reached the next meaningful tier above $20 million.

Below that, we mostly find businesses in the single-digit or low-double-digit millions.

At the same time, Agreena covers around five million hectares, Boomitra works across roughly five million acres and Regrow serves more than 100 organizations while monitoring an enormous global land base.

That gap between operational reach and disclosed revenue is probably the defining feature of regenerative agriculture today.

The sector is no longer small in terms of farms, acreage, products or corporate interest. It is still early when measured by the number of independent startups generating $20 million, $50 million or $100 million a year.

What does the strict regenerative agriculture startup revenue ranking look like?

Pivot Bio currently sits far ahead of the other independent regenerative agriculture startups for which we found defensible revenue figures.

For this stricter table, we remove old incumbent businesses, consolidated divisions, acquired companies and public groups whose scale makes the startup comparison less useful.

We also leave out companies where acreage, customers or contracts are strong but annual revenue is not publicly available.

That gives us a much shorter ranking than the broad market table.

Rank	Startup	Best revenue figure	Period	Main business
1	Pivot Bio	>$100M	FY2023	Microbial nitrogen
2	Grow Indigo	₹207 Cr (~$24M)	FY2025	Biological inputs + carbon farming
3	Advancing Eco Agriculture	$18.0M	2023	Regenerative agronomy + crop inputs
4	Elicit Plant	€5M–€8M	Recent disclosed scale	Biostimulants
5	Biome Makers	€5.7M	2025	Soil microbiome intelligence
6	Varaha	₹430M (~$4.8M)	Latest reported financial year	Agricultural carbon
7	BioPrime Agrisolutions	₹10.8 Cr (~$1.3M)	FY2025	Biological crop inputs
8	eAgronom	€976,863	2025	Farm software + carbon programs

So what are the top regenerative agriculture startups by revenue?

Pivot Bio is currently the clearest revenue leader among true regenerative agriculture startups, with more than $100 million of FY2023 revenue.

Grow Indigo is the strongest challenger we can place with recent revenue evidence, at ₹207 crore in FY2025. Advancing Eco Agriculture follows at roughly $18 million based on its last detailed financial report.

After those three, disclosed startup revenue drops into the single-digit millions.

That is the main conclusion from the research. The broader regenerative agriculture economy is already capable of supporting €500 million biosolutions businesses, but the independent startup market underneath it is still surprisingly small financially.

Biological inputs have produced nearly all of the biggest revenue outcomes so far. Carbon farming, soil software and MRV have built much larger footprints than their disclosed revenue suggests, and some of those businesses may eventually move much higher in the ranking.

For now, though, there is a very large gap between Pivot Bio and almost everyone else.